
PainChek PCK.AX plunges as much as ~31% to A$0.038; marks biggest intraday pct drop since June 18, 2017
Stock hits lowest since May 7
Medical devices maker flags potential delay in U.S. FDA clearance for its pain assessment app
Expects clearance by mid-to-late September instead of the first half of 2025 anticipated earlier
About 14.3 mln shares traded in stock's busiest day since February 18, 2021
PCK last up 21.8%, taking YTD gains to 48.3%